FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical compositions from animal raw materials and can be used for treatment and rehabilitation of different types of endometriosis and some cancers. Pharmaceutical composition for treating endometriosis follicular fluid is obtained from cattle, which is isolated from serum albumin and protein of TGF-β family, having immunospecificity of inhibin βA, and NaCl salt is added in following ratio, wt%: protein of TGF-β family, having immunospecificity of inhibin βA: 0.0000015-0.3 %; serum albumin: 3.5 %; NaCl salt: balance.
EFFECT: use of present invention provides more efficient treatment of endometriosis due to significant reduction or complete absence of relapses after a course of treatment, absence of significant side effects, normalisation of hormonal status.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING FOLLICULAR PROTEIN PREPARATION AND PREPARATION PRODUCED BY SAID METHOD | 2014 |
|
RU2591819C2 |
| METHOD OF TREATING INFLAMMATORY PROCESSES OF JOINTS AND PROSTATITIS | 2018 |
|
RU2703257C1 |
| PROTEIN-PEPTIDE COMPLEX INCREASING THE VIABILITY OF FOLLICULES IN MAMMAL OVARIANS | 2017 |
|
RU2660587C1 |
| METHOD OF ALPHA-FETOPROTEIN PREPARING | 1995 |
|
RU2100031C1 |
| WAY OF ENDOMETRIOSIS TREATMENT | 2008 |
|
RU2359684C1 |
| METHOD TO PRODUCE ESTROGEN-BINDING PROTEIN ASSOCIATED WITH MALIGNANT TUMORS | 2012 |
|
RU2489440C1 |
| PHARMACOLOGICAL SUBSTANCE OF MEMBRANOTROPIC HOMEOSTATIC TISSUE-SPECIFIC BIOREGULATORS ISOLATED FROM VARIOUS TISSUES AND BIOLOGICAL FLUIDS OF ANIMALS | 2021 |
|
RU2797514C1 |
| PROTEIN-PEPTIDE COMPLEX AND DRUG PREPARATION AGENT, WHICH IS PROTEIN-PEPTIDE COMPLEX | 2018 |
|
RU2716819C1 |
| SUBSTANCE FOR PRODUCING AN AGENT WHICH INCREASES VIABILITY AND MOTILITY OF SPERMATOZOA IN MAMMALS | 2018 |
|
RU2725491C2 |
| PROTEIN-PEPTIDE COMPLEX HAVING A PROTECTIVE ACTION ON THE STATE OF TISSUES OF THE POSTERIOR EYE - SCLERAL SHELL, RETINA, PIGMENT EPITHELIUM, CHOROID | 2018 |
|
RU2701566C1 |
